|
|
System Biosciences (SBI)
recognizes the need to invest in and maintain a comprehensive intellectual property
(IP) portfolio that protects its unique and novel approaches to understand
gene and protein function in complex biological systems. SBI currently has a
number of pending patents and licensing agreements related to lentiviral
vectors, effector library technology, lentiviral reporter vectors, and
fluorescent reporters. For information concerning our IP position around
these or other technologies, please contact
us.
Supplementing this IP
investment, SBI has an active in-licensing program to
obtain key complementary technologies that enhance the utility of our
systems. If you have technology that might interest us,
please let us know.
|
